DJAM:XETRA:XETRA-Lyxor UCITS ETF Dow Jones Industrial Average (EUR)

ETF | Others |

Last Closing

USD 381.45

Change

+2.30 (+0.61)%

Market Cap

USD 0.31B

Volume

3.57K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.17 (+2.33%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.38 (+2.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.62 (+2.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.63 (+2.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.66 (+2.76%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+3.78 (+2.75%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

+0.79 (+1.74%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.15 (+2.31%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.54 (+1.22%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.43 (+1.90%)

USD 79.79B

ETFs Containing DJAM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.50% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.50% 67% D+ 66% D+
Trailing 12 Months  
Capital Gain 17.46% 63% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.46% 62% D 63% D
Trailing 5 Years  
Capital Gain 55.00% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.00% 74% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.97% 75% C 73% C
Dividend Return 11.48% 76% C+ 73% C
Total Return 0.51% 42% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 11.33% 55% F 64% D
Risk Adjusted Return 101.34% 97% N/A 97% N/A
Market Capitalization 0.31B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.